T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
AeroVironment
AVAV
$9.59B
| $566K | ﹤0.01% |
9,277
-4,866
| -34% | -$304K |
|
|
HTLF
1927
DELISTED
Heartland Financial USA, Inc.
HTLF
| $566K | ﹤0.01% |
18,736
-455
| -2% | -$19.9K |
|
1928
Adtran
ADTN
$658M
| $564K | ﹤0.01% |
73,383
+19,672
| +37% | +$168K |
|
1929
Univest Financial
UVSP
$1.19B
| $564K | ﹤0.01% |
34,544
+6,030
| +21% | +$138K |
|
|
KAMN
1930
DELISTED
Kaman Corp
KAMN
| $563K | ﹤0.01% |
14,640
+133
| +0.9% | +$7.51K |
|
|
HTZ
1931
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $560K | ﹤0.01% |
90,631
-3,199
| -3% | -$43.2K |
|
|
GWB
1932
DELISTED
Great Western Bancorp, Inc.
GWB
| $558K | ﹤0.01% |
27,258
+300
| +1% | +$8.47K |
|
|
SCS
1933
DELISTED
Steelcase
SCS
| $556K | ﹤0.01% |
56,292
+22,117
| +65% | +$365K |
|
1934
Lindsay Corp
LNN
$1.17B
| $554K | ﹤0.01% |
6,052
+70
| +1% | +$6.9K |
|
1935
Teva Pharmaceuticals
TEVA
$42.6B
| $553K | ﹤0.01% |
61,630
+31,730
| +106% | +$325K |
|
1936
First Financial Corp
THFF
$975M
| $552K | ﹤0.01% |
16,371
+7,096
| +77% | +$286K |
|
1937
Ennis
EBF
$559M
| $549K | ﹤0.01% |
29,218
+5,454
| +23% | +$109K |
|
|
IVC
1938
DELISTED
Invacare Corporation
IVC
| $549K | ﹤0.01% |
73,927
+210
| +0.3% | +$1.63K |
|
1939
National Beverage
FIZZ
$2.93B
| $548K | ﹤0.01% |
25,706
+1,570
| +7% | +$34.3K |
|
|
CSII
1940
DELISTED
Cardiovascular Systems, Inc.
CSII
| $547K | ﹤0.01% |
15,541
+160
| +1% | +$6.74K |
|
|
WDR
1941
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $546K | ﹤0.01% |
47,982
+5,100
| +12% | +$76K |
|
|
CADE
1942
DELISTED
Cadence Bancorporation
CADE
| $545K | ﹤0.01% |
83,270
+12,150
| +17% | +$168K |
|
|
TWO
1943
Two Harbors Investment
TWO
$1.26B
| $543K | ﹤0.01% |
35,651
+3,365
| +10% | +$172K |
|
1944
BGC Group
BGC
$5.2B
| $542K | ﹤0.01% |
215,113
+23,384
| +12% | +$114K |
|
1945
Camden National
CAC
$996M
| $542K | ﹤0.01% |
17,221
+7,823
| +83% | +$329K |
|
|
ADSW
1946
DELISTED
Advanced Disposal Services Inc
ADSW
| $542K | ﹤0.01% |
16,522
-1,156,756
| -99% | -$37.9M |
|
|
CBB
1947
DELISTED
Cincinnati Bell Inc.
CBB
| $542K | ﹤0.01% |
37,044
-11,210
| -23% | -$146K |
|
1948
ICF International
ICFI
$1.6B
| $541K | ﹤0.01% |
7,868
+123
| +2% | +$10K |
|
1949
MYR Group
MYRG
$5.1B
| $541K | ﹤0.01% |
20,655
+137
| +0.7% | +$3.84K |
|
1950
Newmark Group
NMRK
$2.77B
| $541K | ﹤0.01% |
127,190
+21,653
| +21% | +$212K |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.